prostacyclin analog | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,143 results for “prostacyclin analog”

Trials

View all 1447 →

Enhanced Assisted Reproductive Technology Pregnancy Rate by Prostacyclin Analog (Iloprost)

100 participants · First posted Mar 9, 2012

Platelet Reactivity and Treatment With Prostacyclin Analogues in Pulmonary Arterial Hypertension

80 participants · First posted Oct 8, 2020

Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication

6 participants · First posted Dec 31, 2010

Drugs

View all 331 →

Prostacyclin analog (CoNCERT)

Prostacyclin analogue with subcutaneous delivery (Eicos Sciences)

Iloprost(Ventavis)

Conditions: NYHA class III Pulmonary arterial hypertension, NYHA class IV Pulmonary arterial hypertension

C₂₂H₃₂O₄ · Rx

Organizations

View all 12 →

ANALOG PHARMA, INC.

United States

ON Semiconductor

Metsera

News

View all 353 →

Pharmosa Biopharm's Inhaled Drug L606 Wins China Approval to Launch Global Phase 3

Systemic Sclerosis Pipeline Shows Promise with 50+ Therapies in Development

Court Dismisses United Therapeutics' Challenge Against Liquidia's YUTREPIA, Clearing Path for May Launch

Page 1 of 215